gba-group.com

With the acquisition of ICCR-Roßdorf GmbH (ICCR-Roßdorf), GBA Group expands its toxicology services for customers in the chemical, medical device, and pharmaceutical industries. This move reflects GBA Group's strategic ambition to establish itself broadly as an international life science service provider through targeted portfolio expansions and investments in leading CROs.
ICCR-Roßdorf, established in 1986, currently operates with nearly 100 employees at its headquarters in Roßdorf near Darmstadt. The company specializes in investigating the genotoxic potential of pharmaceuticals, agrochemicals, cosmetics, and chemicals. Additionally, for customers in the medical device sector, ICCR-Roßdorf offers modified protocols for investigating the effects of extracts.